主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
版块:
基础:
利润货币:
日范围
年范围
日变化
+6.42%
每月变动
-13.43%
6个月变化
+346.15%
年变化
+256.92%
前一天收盘价
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
交易量
15
市场
股票
医疗保健
IPSC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
85.03 M
86.05 M
86.16 M
86.39 M
87.31 M
—
Valuation ratios
Enterprise value
92.81 M
28.46 M
-10.85 M
-8.61 M
-12.04 M
-3.04 M
Price to earnings ratio
-0.93
-0.63
-1.76
-2.07
-1.66
-6.12
Price to sales ratio
43.4
12.06
0.35
0.42
0.38
13.21
Price to cash flow ratio
-1.01
-0.72
-0.33
-0.4
-0.38
-1.82
Price to book ratio
0.15
0.49
0.05
0.06
0.05
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.1
0.24
0.11
0.14
0.6
Return on equity %
0.16
0.22
0.32
0.16
0.2
0.89
Return on invested capital %
67.18
67.16
138.89
98.45
114.82
419.32
Gross margin %
100
100
100
—
—
—
Operating margin %
4 398.1
893.67
67.95
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
3 947.66
864.65
70.13
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.39
1.5
11.7
10.72
6.25
30.16
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.33
0
0
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.33
0.31
0.4
0.32
0.3
1.33
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.34
2.41
1.92
1.81
1.54
7.67
Net current asset value per share
2.43
2.47
1.97
1.86
1.59
7.89
Tangible book value per share
1.86
1.62
2.4
2.04
1.64
7.69
Working capital per share
2.2
0.82
1.8
1.68
1.34
5.64
Book value per share
2.31
2.05
2.79
2.43
2.04
9.32
新闻
TD Cowen首次覆盖Century Therapeutics股票,评级为买入
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street重申Century Therapeutics股票买入评级,目标价6.60美元
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street下调世纪治疗(Century Therapeutics)股价目标至6.60美元
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors